Friday, April 21, 2023

Now, The End Payor Plaintiffs (Insurers, Mostly) Have Been Paid By Merck And Glenmark -- To Settle Zetia® Antitrust Matter.


It all actually happened yesterday, but only appeared on the Norfolk, Virginia federal docket this morning.

This still leaves the hospitals, retail pharmacies and other retail purchasers in the litigation. Here's the order:

. . .Before jury selection commenced as scheduled, the court was advised that the End Payor Plaintiffs (EPPs) had reached a settlement agreement with the Merck Defendants and the Glenmark Defendants. Thereafter, following a brief delay, jury selection resumed for the remaining parties at 11:30 AM. . . .

Jurors (Panel B of 34 jurors) appeared as summoned, sworn, and examined on voir dire. Jurors not serving excused.

Jurors (Panel A of 32 remaining jurors) appeared and continued to be examined on voir dire along with remaining jurors on Panel B. Jurors not serving excused.

The court directed that the remaining Jurors from Panel A and Panel B return on April 24, 2023, at 10:00 a.m. Jury trial continued to April 24, 2023, at 10:00 a.m.

Court adjourned. . . .


Onward, grinning -- Condor wonders: will all the others settle over the weekend? We shall see. . . on a flawless warm Spring Friday in the city of big shoulders. Be excellent to one another.

नमस्ते

No comments: